Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction
AssigneeDsm IP Assets B.V.
InventorsLucas Cyril Gerard van der Heyden, Lucas Johannes Cornelis van Loon, Luppo Edens, Antonius Johannes Maria Wagenmakers
Life of this patent
Estimating the term…
Abstract
The present invention discloses a composition comprising an insulin sensitizer and a peptide fraction, which promotes significant reduction in blood glucose levels and stabilizes blood glucose levels in individuals with type 2 diabetes.
Claims20
A composition suitable for oral consumption comprising an insulin sensitizer and a peptide fraction of a protein hydrolysate, wherein at least 70 molar % of peptides in the peptide fraction have a molecular weight below 2000 Da and at least 20 molar % of peptides with a molecular weight below 2000 Da are present as di- and/or tripeptides.
A method of reducing insulin resistance or delaying development of diabetes using a composition comprised of a peptide fraction of a protein hydrolysate, the method comprising:
- (a) providing the composition to a subject in need thereof and
- (b) having the subject ingest the composition whereby insulin resistance is reduced or development of diabetes is delayed.
A method of treating type 2 diabetes using a composition comprised of a peptide fraction of a protein hydrolysate, the method comprising:
- (a) providing the composition to a subject being treated for type 2 diabetes with an insulin sensitizer and
- (b) ingesting the composition whereby blood glucose is lowered.
Dependencies are inferred from the claim text.